Changes
On November 1, 2022 at 3:24:26 PM UTC, Jonathan Berry:
-
Added tag featured to Malawi Integrated HIV Program Report 2021 Q1
f | 1 | { | f | 1 | { |
2 | "author": "", | 2 | "author": "", | ||
3 | "author_email": "cmkandawire@hivmw.org", | 3 | "author_email": "cmkandawire@hivmw.org", | ||
4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | 4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | ||
n | 5 | "groups": [], | n | 5 | "groups": [ |
6 | { | ||||
7 | "description": "Group for publications", | ||||
8 | "display_name": "Publication", | ||||
9 | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | ||||
10 | "image_display_url": | ||||
11 | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | ||||
12 | "name": "publication", | ||||
13 | "title": "Publication" | ||||
14 | } | ||||
15 | ], | ||||
6 | "id": "394f8196-2634-40b4-bd18-c9c12a7cdf16", | 16 | "id": "394f8196-2634-40b4-bd18-c9c12a7cdf16", | ||
7 | "isopen": false, | 17 | "isopen": false, | ||
8 | "license_id": "notspecified", | 18 | "license_id": "notspecified", | ||
9 | "license_title": "License not specified", | 19 | "license_title": "License not specified", | ||
10 | "maintainer": null, | 20 | "maintainer": null, | ||
11 | "maintainer_email": null, | 21 | "maintainer_email": null, | ||
12 | "metadata_created": "2022-08-30T09:24:05.615214", | 22 | "metadata_created": "2022-08-30T09:24:05.615214", | ||
n | 13 | "metadata_modified": "2022-08-30T09:34:25.560058", | n | 23 | "metadata_modified": "2022-11-01T15:24:26.307690", |
14 | "name": "malawi-integrated-hiv-program-report-2021-q1", | 24 | "name": "malawi-integrated-hiv-program-report-2021-q1", | ||
15 | "notes": "__Program performance highlights by the end of March 2021 | 25 | "notes": "__Program performance highlights by the end of March 2021 | ||
16 | include:__\r\n\r\n* Scale-up of integrated HIV services had reached | 26 | include:__\r\n\r\n* Scale-up of integrated HIV services had reached | ||
17 | the following number of sites: \r\n * __724__ static | 27 | the following number of sites: \r\n * __724__ static | ||
18 | and __154__ outreach HIV testing sites.\r\n * __760__ (static) | 28 | and __154__ outreach HIV testing sites.\r\n * __760__ (static) | ||
19 | ART sites; __605__ of these started at least one pregnant or | 29 | ART sites; __605__ of these started at least one pregnant or | ||
20 | breastfeeding woman.\r\n * __699__ sites with HIV-exposed | 30 | breastfeeding woman.\r\n * __699__ sites with HIV-exposed | ||
21 | children in follow-up.\r\n* 670,567 persons were tested for HIV by a | 31 | children in follow-up.\r\n* 670,567 persons were tested for HIV by a | ||
22 | trained provider and received their results;\r\n131,552 (20%) accessed | 32 | trained provider and received their results;\r\n131,552 (20%) accessed | ||
23 | HIV testing for the first time; 539,015 (80%) were repeat testers and | 33 | HIV testing for the first time; 539,015 (80%) were repeat testers and | ||
24 | 22,296 (4%) of these received confirmatory testing (after having | 34 | 22,296 (4%) of these received confirmatory testing (after having | ||
25 | tested positive in the past). 20,078 (3.1%) clients received a | 35 | tested positive in the past). 20,078 (3.1%) clients received a | ||
26 | positive result for the first time.\r\n* A total of 104,724 people | 36 | positive result for the first time.\r\n* A total of 104,724 people | ||
27 | received 173,272 self-test kits; 77,033 (44%) of these were for use by | 37 | received 173,272 self-test kits; 77,033 (44%) of these were for use by | ||
28 | the recipient and 96,239 (56%) for onward distribution to sex partners | 38 | the recipient and 96,239 (56%) for onward distribution to sex partners | ||
29 | or other people.\r\n* 18,193 (97%) of 18,802 blood units collected | 39 | or other people.\r\n* 18,193 (97%) of 18,802 blood units collected | ||
30 | were screened for (at least) HIV, hepatitis B and syphilis.\r\n* A | 40 | were screened for (at least) HIV, hepatitis B and syphilis.\r\n* A | ||
31 | cumulative total of 825 clients were referred for PrEP eligibility | 41 | cumulative total of 825 clients were referred for PrEP eligibility | ||
32 | screening and 544 (66%) were found eligible. 277 newly started PrEP | 42 | screening and 544 (66%) were found eligible. 277 newly started PrEP | ||
33 | and 177 clients were retained on PrEP at the end of the quarter.\r\n* | 43 | and 177 clients were retained on PrEP at the end of the quarter.\r\n* | ||
34 | 155,575 (99%) of 157,743 women at ANC had their HIV status | 44 | 155,575 (99%) of 157,743 women at ANC had their HIV status | ||
35 | ascertained;\r\n10,724 (7%) of these were HIV positive. 131,564 (95%) | 45 | ascertained;\r\n10,724 (7%) of these were HIV positive. 131,564 (95%) | ||
36 | of 139,169 at maternity had their HIV status ascertained 9,387 (7%) of | 46 | of 139,169 at maternity had their HIV status ascertained 9,387 (7%) of | ||
37 | these were HIV positive.\r\n* 19,682 patients started ART this | 47 | these were HIV positive.\r\n* 19,682 patients started ART this | ||
38 | quarter; 79% were classified as asymptomatic / in WHO stage 1 and | 48 | quarter; 79% were classified as asymptomatic / in WHO stage 1 and | ||
39 | started under the \u201cTest & Treat\u201d policy.\r\n* 871,098 | 49 | started under the \u201cTest & Treat\u201d policy.\r\n* 871,098 | ||
40 | patients were alive and on ART by end of March 2021.2 This means that | 50 | patients were alive and on ART by end of March 2021.2 This means that | ||
41 | 88% of the estimated 986,671 HIV positive population was on ART. 3 ART | 51 | 88% of the estimated 986,671 HIV positive population was on ART. 3 ART | ||
42 | coverage was 78% (44,960/ 57,530) for children4 and 89% (826,138 / | 52 | coverage was 78% (44,960/ 57,530) for children4 and 89% (826,138 / | ||
43 | 929,141) for adults.\r\n* 136,281 (95%) of viral load results from | 53 | 929,141) for adults.\r\n* 136,281 (95%) of viral load results from | ||
44 | routine monitoring were <1000 copies/ml.\r\nViral suppression rates | 54 | routine monitoring were <1000 copies/ml.\r\nViral suppression rates | ||
45 | for routine samples among children (0-14 years) and adults (15+ years) | 55 | for routine samples among children (0-14 years) and adults (15+ years) | ||
46 | were 77% and 96%, respectively.\r\n* 73% of adults and 76% of children | 56 | were 77% and 96%, respectively.\r\n* 73% of adults and 76% of children | ||
47 | were retained alive on ART at 12 months after initiation.\r\n* Out of | 57 | were retained alive on ART at 12 months after initiation.\r\n* Out of | ||
48 | 851,998 patients on first line adult ART 817,888 (97%) had | 58 | 851,998 patients on first line adult ART 817,888 (97%) had | ||
49 | transitioned to TDF/3TC/DTG and only 4,388 (1%) were on TDF/3TC/EFV.", | 59 | transitioned to TDF/3TC/DTG and only 4,388 (1%) were on TDF/3TC/EFV.", | ||
50 | "num_resources": 1, | 60 | "num_resources": 1, | ||
n | 51 | "num_tags": 9, | n | 61 | "num_tags": 10, |
52 | "organization": { | 62 | "organization": { | ||
53 | "approval_status": "approved", | 63 | "approval_status": "approved", | ||
54 | "created": "2021-10-14T11:02:35.234558", | 64 | "created": "2021-10-14T11:02:35.234558", | ||
55 | "description": "The Department of HIV & AIDS (DHA) was established | 65 | "description": "The Department of HIV & AIDS (DHA) was established | ||
56 | in 2001, initially as a unit in the Department of Clinical Services, | 66 | in 2001, initially as a unit in the Department of Clinical Services, | ||
57 | to coordinate the biomedical HIV Program in Malawi. The department now | 67 | to coordinate the biomedical HIV Program in Malawi. The department now | ||
58 | carries responsibility for various HIV related programs including: | 68 | carries responsibility for various HIV related programs including: | ||
59 | sexually transmitted infections (STIs), prevention of mother to child | 69 | sexually transmitted infections (STIs), prevention of mother to child | ||
60 | transmission of HIV (PMTCT), and national voluntary male medical | 70 | transmission of HIV (PMTCT), and national voluntary male medical | ||
61 | circumcision program (VMMC). All these HIV program sub-sections are | 71 | circumcision program (VMMC). All these HIV program sub-sections are | ||
62 | linked to one robust monitoring and evaluation sub-section in the HIV | 72 | linked to one robust monitoring and evaluation sub-section in the HIV | ||
63 | and AIDS Department which technically operates under the Central | 73 | and AIDS Department which technically operates under the Central | ||
64 | Monitoring and Evaluation Department (CMED) of the Ministry of | 74 | Monitoring and Evaluation Department (CMED) of the Ministry of | ||
65 | Health.", | 75 | Health.", | ||
66 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 76 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
67 | "image_url": | 77 | "image_url": | ||
68 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | 78 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | ||
69 | "is_organization": true, | 79 | "is_organization": true, | ||
70 | "name": "dha", | 80 | "name": "dha", | ||
71 | "state": "active", | 81 | "state": "active", | ||
72 | "title": "Department of HIV & AIDS and Viral Hepatitis", | 82 | "title": "Department of HIV & AIDS and Viral Hepatitis", | ||
73 | "type": "organization" | 83 | "type": "organization" | ||
74 | }, | 84 | }, | ||
75 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 85 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
76 | "private": false, | 86 | "private": false, | ||
77 | "program_area": "Care and Treatment", | 87 | "program_area": "Care and Treatment", | ||
78 | "relationships_as_object": [], | 88 | "relationships_as_object": [], | ||
79 | "relationships_as_subject": [], | 89 | "relationships_as_subject": [], | ||
80 | "resources": [ | 90 | "resources": [ | ||
81 | { | 91 | { | ||
82 | "cache_last_updated": null, | 92 | "cache_last_updated": null, | ||
83 | "cache_url": null, | 93 | "cache_url": null, | ||
84 | "created": "2022-08-30T09:25:41.056469", | 94 | "created": "2022-08-30T09:25:41.056469", | ||
85 | "description": "", | 95 | "description": "", | ||
86 | "format": "PDF", | 96 | "format": "PDF", | ||
87 | "hash": "", | 97 | "hash": "", | ||
88 | "id": "2e4da787-ec50-4165-9b43-276da2c09912", | 98 | "id": "2e4da787-ec50-4165-9b43-276da2c09912", | ||
89 | "last_modified": "2022-08-30T09:25:40.989527", | 99 | "last_modified": "2022-08-30T09:25:40.989527", | ||
90 | "lfs_prefix": | 100 | "lfs_prefix": | ||
91 | "dha/malawi-integrated-hiv-program-report-2021-q1", | 101 | "dha/malawi-integrated-hiv-program-report-2021-q1", | ||
92 | "metadata_modified": "2022-08-30T09:25:41.222238", | 102 | "metadata_modified": "2022-08-30T09:25:41.222238", | ||
93 | "mimetype": "application/pdf", | 103 | "mimetype": "application/pdf", | ||
94 | "mimetype_inner": null, | 104 | "mimetype_inner": null, | ||
95 | "name": "Malawi Integrated HIV Program Report 2021 Q1", | 105 | "name": "Malawi Integrated HIV Program Report 2021 Q1", | ||
96 | "package_id": "394f8196-2634-40b4-bd18-c9c12a7cdf16", | 106 | "package_id": "394f8196-2634-40b4-bd18-c9c12a7cdf16", | ||
97 | "position": 0, | 107 | "position": 0, | ||
98 | "resource_type": null, | 108 | "resource_type": null, | ||
99 | "sha256": | 109 | "sha256": | ||
100 | "dc7b5ac9ec7c20486455365a29dc196043aa716965d2389fd607ee48ee6bf077", | 110 | "dc7b5ac9ec7c20486455365a29dc196043aa716965d2389fd607ee48ee6bf077", | ||
101 | "size": 3600910, | 111 | "size": 3600910, | ||
102 | "state": "active", | 112 | "state": "active", | ||
103 | "url": | 113 | "url": | ||
104 | 6da2c09912/download/malawi_integrated_hiv_program_report_2021_q1.pdf", | 114 | 6da2c09912/download/malawi_integrated_hiv_program_report_2021_q1.pdf", | ||
105 | "url_type": "upload" | 115 | "url_type": "upload" | ||
106 | } | 116 | } | ||
107 | ], | 117 | ], | ||
108 | "state": "active", | 118 | "state": "active", | ||
109 | "tags": [ | 119 | "tags": [ | ||
110 | { | 120 | { | ||
111 | "display_name": "HTC", | 121 | "display_name": "HTC", | ||
112 | "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", | 122 | "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", | ||
113 | "name": "HTC", | 123 | "name": "HTC", | ||
114 | "state": "active", | 124 | "state": "active", | ||
115 | "vocabulary_id": null | 125 | "vocabulary_id": null | ||
116 | }, | 126 | }, | ||
117 | { | 127 | { | ||
118 | "display_name": "PMTCT-ART", | 128 | "display_name": "PMTCT-ART", | ||
119 | "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", | 129 | "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", | ||
120 | "name": "PMTCT-ART", | 130 | "name": "PMTCT-ART", | ||
121 | "state": "active", | 131 | "state": "active", | ||
122 | "vocabulary_id": null | 132 | "vocabulary_id": null | ||
123 | }, | 133 | }, | ||
124 | { | 134 | { | ||
125 | "display_name": "Report", | 135 | "display_name": "Report", | ||
126 | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | 136 | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | ||
127 | "name": "Report", | 137 | "name": "Report", | ||
128 | "state": "active", | 138 | "state": "active", | ||
129 | "vocabulary_id": null | 139 | "vocabulary_id": null | ||
130 | }, | 140 | }, | ||
131 | { | 141 | { | ||
132 | "display_name": "anc", | 142 | "display_name": "anc", | ||
133 | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | 143 | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | ||
134 | "name": "anc", | 144 | "name": "anc", | ||
135 | "state": "active", | 145 | "state": "active", | ||
136 | "vocabulary_id": null | 146 | "vocabulary_id": null | ||
137 | }, | 147 | }, | ||
138 | { | 148 | { | ||
139 | "display_name": "blood safety", | 149 | "display_name": "blood safety", | ||
140 | "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", | 150 | "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", | ||
141 | "name": "blood safety", | 151 | "name": "blood safety", | ||
142 | "state": "active", | 152 | "state": "active", | ||
143 | "vocabulary_id": null | 153 | "vocabulary_id": null | ||
144 | }, | 154 | }, | ||
145 | { | 155 | { | ||
t | t | 156 | "display_name": "featured", | ||
157 | "id": "22f37483-07b1-400c-a6e5-16ff1153a217", | ||||
158 | "name": "featured", | ||||
159 | "state": "active", | ||||
160 | "vocabulary_id": null | ||||
161 | }, | ||||
162 | { | ||||
146 | "display_name": "hiv", | 163 | "display_name": "hiv", | ||
147 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | 164 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | ||
148 | "name": "hiv", | 165 | "name": "hiv", | ||
149 | "state": "active", | 166 | "state": "active", | ||
150 | "vocabulary_id": null | 167 | "vocabulary_id": null | ||
151 | }, | 168 | }, | ||
152 | { | 169 | { | ||
153 | "display_name": "maternity", | 170 | "display_name": "maternity", | ||
154 | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | 171 | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | ||
155 | "name": "maternity", | 172 | "name": "maternity", | ||
156 | "state": "active", | 173 | "state": "active", | ||
157 | "vocabulary_id": null | 174 | "vocabulary_id": null | ||
158 | }, | 175 | }, | ||
159 | { | 176 | { | ||
160 | "display_name": "sti", | 177 | "display_name": "sti", | ||
161 | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | 178 | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | ||
162 | "name": "sti", | 179 | "name": "sti", | ||
163 | "state": "active", | 180 | "state": "active", | ||
164 | "vocabulary_id": null | 181 | "vocabulary_id": null | ||
165 | }, | 182 | }, | ||
166 | { | 183 | { | ||
167 | "display_name": "viral load", | 184 | "display_name": "viral load", | ||
168 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | 185 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | ||
169 | "name": "viral load", | 186 | "name": "viral load", | ||
170 | "state": "active", | 187 | "state": "active", | ||
171 | "vocabulary_id": null | 188 | "vocabulary_id": null | ||
172 | } | 189 | } | ||
173 | ], | 190 | ], | ||
174 | "title": "Malawi Integrated HIV Program Report 2021 Q1", | 191 | "title": "Malawi Integrated HIV Program Report 2021 Q1", | ||
175 | "type": "dataset", | 192 | "type": "dataset", | ||
176 | "url": null, | 193 | "url": null, | ||
177 | "version": null, | 194 | "version": null, | ||
178 | "year": "2021" | 195 | "year": "2021" | ||
179 | } | 196 | } |